{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:35:21Z","timestamp":1772217321468,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002273"],"award-info":[{"award-number":["UL1TR002273"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study explored the risk mitigation practices of multidisciplinary oncology health-care personnel for the nonmedical use of opioids in people with cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An anonymous, cross-sectional descriptive survey was administered via email to eligible providers over 4 weeks at The Ohio State University\u2019s Arthur G. James Cancer Hospital. The survey asked about experiences and knowledge related to opioid use disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The final sample of 773 participants included 42 physicians, 213 advanced practice providers (APPs consisted of advanced practice nurses, physician assistants, and pharmacists), and 518 registered nurses. Approximately 40% of participants responded feeling \u201cnot confident\u201d in addressing medication diversion. The most frequent risk reduction measure was \u201cChecking the prescription drug monitoring program\u201d when prescribing controlled medications, reported by physicians (n\u2005=\u200529, 78.4%) and APPs (n\u2005=\u2005164, 88.6%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>People with cancer are not exempt from the opioid epidemic and may be at risk for nonmedical opioid use (NMOU) and substance use disorders. Implementing risk reduction strategies with every patient, with a harm reduction versus abstinence focus, minimizes harmful consequences and improves. This study highlights risk mitigation approaches for NMOU, representing an opportunity to improve awareness among oncology health-care providers. Multidisciplinary oncology teams are ideally positioned to navigate patients through complex oncology and health-care journeys.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad214","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T15:03:46Z","timestamp":1690470226000},"page":"996-1004","source":"Crossref","is-referenced-by-count":3,"title":["Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-4379","authenticated-orcid":false,"given":"Gretchen A","family":"McNally","sequence":"first","affiliation":[{"name":"Department of Nursing, James Cancer Hospital, The Ohio State University , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Ridgway-Limle","sequence":"additional","affiliation":[{"name":"Department of Nursing, James Cancer Hospital, The Ohio State University , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Rosselet","sequence":"additional","affiliation":[{"name":"College of Nursing, The Ohio State University , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-8169","authenticated-orcid":false,"given":"Robert","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, College of Medicine, The Ohio State University , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"4","key":"2023110708532800400_CIT0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41571-018-0143-7","article-title":"Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer","volume":"16","author":"Arthur","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2023110708532800400_CIT0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/pmt-2018-0031","article-title":"Cancer pain: where are we now","volume":"9","author":"Magee","year":"2019","journal-title":"Pain Manag"},{"issue":"10","key":"2023110708532800400_CIT0003","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1634\/theoncologist.2019-0277","article-title":"Navigating challenging conversations about nonmedical opioid use in the context of oncology","volume":"24","author":"Sager","year":"2019","journal-title":"Oncologist"},{"key":"2023110708532800400_CIT0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.genhosppsych.2019.04.016","article-title":"A systematic review of substance use and substance use disorders in patients with cancer","volume":"60","author":"Yusufov","year":"2019","journal-title":"Gen Hosp Psychiatry."},{"issue":"3","key":"2023110708532800400_CIT0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11864-020-0713-7","article-title":"Opioids and cancer mortality","volume":"21","author":"Amaram-Davila","year":"2020","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"2023110708532800400_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"2023110708532800400_CIT0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/imj.13449","article-title":"Opioid addiction and misuse in adult and adolescent patients with cancer","volume":"47","author":"Pinkerton","year":"2017","journal-title":"Intern Med J"},{"issue":"3","key":"2023110708532800400_CIT0008","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1634\/theoncologist.2019-0540","article-title":"Best practices in the management of nonmedical opioid use in patients with cancer-related pain","volume":"25","author":"Ulker","year":"2020","journal-title":"Oncologist"},{"issue":"19","key":"2023110708532800400_CIT0009","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMp2103274","article-title":"Bringing harm reduction into health policy - combating the overdose crisis","volume":"384","author":"Sue","year":"2021","journal-title":"N Engl J Med"},{"key":"2023110708532800400_CIT0010","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5"},{"key":"2023110708532800400_CIT0011","volume-title":"American Society of Addiction Medicine Releases New Definition of Addiction to Advance Greater Understanding of the Complex, Chronic Disease","author":"American Society of Addiction Medicine","year":"2019"},{"issue":"2","key":"2023110708532800400_CIT0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpainsymman.2020.11.033","article-title":"Identifying prevalence of and risk factors for abnormal urine drug tests in cancer pain patients","volume":"62","author":"Leap","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2023110708532800400_CIT0013","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s11606-020-06409-6","article-title":"A harm reduction approach to treating opioid use disorder in an independent primary care practice: a qualitative study","volume":"36","author":"Kapadia","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"6","key":"2023110708532800400_CIT0014","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1188\/19.CJON.655-658","article-title":"Managing addiction: guidelines for patients with cancer","volume":"23","author":"McNally","year":"2019","journal-title":"Clin J Oncol Nurs"},{"issue":"Suppl 3","key":"2023110708532800400_CIT0015","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: a rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2023110708532800400_CIT0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1049909118806664","article-title":"Dying on hospice in the midst of an opioid crisis: what should we do now","volume":"36","author":"Gabbard","year":"2019","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"2023110708532800400_CIT0017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/curroncol28010086","article-title":"Managing opioids and mitigating risk: a survey of attitudes, confidence and practices of oncology health care professionals","volume":"28","author":"Tedesco","year":"2021","journal-title":"Curr Oncol"},{"issue":"3","key":"2023110708532800400_CIT0018","article-title":"Addressing the opioid crisis through an interdisciplinary task force in Cincinnati, Ohio, USA","volume":"8","author":"MacKinnon","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"2023110708532800400_CIT0019","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"2023110708532800400_CIT0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"2","key":"2023110708532800400_CIT0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1526-4637.2005.05031.x","article-title":"Universal precautions in pain medicine: a rational approach to the treatment of chronic pain","volume":"6","author":"Gourlay","year":"2005","journal-title":"Pain Med"},{"issue":"5.5","key":"2023110708532800400_CIT0022","first-page":"595","article-title":"Managing pain in patients and survivors: challenges within the United States opioid crisis","volume":"17","author":"Paice","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"2023110708532800400_CIT0023","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/theoncologist.2019-0301","article-title":"Risk assessment and monitoring of patients with cancer receiving opioid therapy","volume":"24","author":"Paice","year":"2019","journal-title":"Oncologist"},{"issue":"27","key":"2023110708532800400_CIT0024","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of clinical oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol."},{"issue":"3","key":"2023110708532800400_CIT0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cncr.33961","article-title":"Approaches to opioid prescribing in cancer survivors: lessons learned from the general literature","volume":"128","author":"Jones","year":"2022","journal-title":"Cancer"},{"issue":"11","key":"2023110708532800400_CIT0026","doi-asserted-by":"crossref","first-page":"e0225460","DOI":"10.1371\/journal.pone.0225460","article-title":"Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: the need to expand substance use disorder treatment and harm reduction services","volume":"14","author":"Thakarar","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"2023110708532800400_CIT0027","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00952990.2021.1937635","article-title":"Primary prevention of prescription opioid diversion: a systematic review of medication disposal interventions","volume":"47","author":"Sch\u00e4fer","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"2023110708532800400_CIT0028","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/00952990.2019.1708086","article-title":"Gender differences in diversion among non-medical users of prescription opioids and sedatives","volume":"46","author":"Milani","year":"2020","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"11","key":"2023110708532800400_CIT0029","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1634\/theoncologist.2019-0242","article-title":"Safe opioid use, storage, and disposal strategies in cancer pain management","volume":"24","author":"Reddy","year":"2019","journal-title":"Oncologist"},{"issue":"4","key":"2023110708532800400_CIT0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpainsymman.2020.09.013","article-title":"Confirmed medication diversion in hospice care: qualitative findings from a national sample of agencies","volume":"61","author":"Ware","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"29","key":"2023110708532800400_CIT0031","first-page":"1","article-title":"Controlled substance agreements for opioids in a primary care practice","volume":"10","author":"Philpot","year":"2017","journal-title":"J Pharm Policy Pract"},{"issue":"11","key":"2023110708532800400_CIT0032","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3949\/ccjm.83a.15172","article-title":"Breaking the pain contract: a better controlled-substance agreement for patients on chronic opioid therapy","volume":"83","author":"Tobin","year":"2016","journal-title":"Cleve Clin J Med"},{"issue":"12","key":"2023110708532800400_CIT0033","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11916-022-01091-1","article-title":"Pill counting as an intervention to enhance compliance and reduce adverse outcomes with analgesics prescribed for chronic pain conditions: a systematic review","volume":"26","author":"Gill","year":"2022","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"2023110708532800400_CIT0034","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1634\/theoncologist.2019-0525","article-title":"Urine drug testing in cancer pain management","volume":"25","author":"Arthur","year":"2020","journal-title":"Oncologist"},{"key":"2023110708532800400_CIT0035","volume-title":"FDA Recommends Health Care Professionals Discuss Naloxone with All Patients When Prescribing Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder","author":"FDA","year":"2020"},{"issue":"1","key":"2023110708532800400_CIT0036","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mcna.2021.09.002","article-title":"Harm reduction in health care settings","volume":"106","author":"Chan","year":"2022","journal-title":"Med Clin North Am"},{"issue":"6","key":"2023110708532800400_CIT0037","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/jpm.2023.0047","article-title":"Buprenorphine initiation: low-dose methods #457","volume":"26","author":"Ho","year":"2023","journal-title":"J Palliat Med"},{"issue":"1","key":"2023110708532800400_CIT0038","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jpm.2022.0399","article-title":"Top ten tips palliative care clinicians should know about buprenorphine","volume":"26","author":"Neale","year":"2023","journal-title":"J Palliat Med"},{"key":"2023110708532800400_CIT0039","volume-title":"Consolidated Appropriations Act of 2023","author":"US Department of Justice","year":"2023"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/11\/996\/52772317\/oyad214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/11\/996\/52772317\/oyad214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:54:25Z","timestamp":1699347265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/28\/11\/996\/7232249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,7,27]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad214","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,27]]}}}